Arecor Therapeutics logo

Arecor Therapeutics

Advancing today’s therapies to enable healthier lives

35 employees · est. 2007 · Cambridge, United Kingdom

VS
Nicox logo

Nicox

Maintain vision and improve ocular health

46 employees · est. 1996 · Valbonne, France

Nicox is the older company (2007 vs 1996).

Side-by-Side Comparison

Arecor Therapeutics Nicox
Founded
2007 1996 older
Headquarters
Cambridge, United Kingdom Valbonne, France
Employees
35 46
Industry
Biopharma, Biotechnology, Education Biotechnology, Health Care, Medical Devices
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
$26.56M $197.30M
Funding Rounds
11 5
Services
Drug development for diabetes, Oral delivery of peptides, Development of enhanced therapeutic medicines using Arestat technology Not tracked yet
Target Customers
Pharmaceutical companies, Medtech companies, Healthcare providers focusing on diabetes and cardiometabolic diseases Not tracked yet
Taxonomy
Biopharmaceutical, Innovative Formulation, Arestat Platform, Diabetes Treatment, Proprietary Products, Therapeutic Enhancement, Ready-to-Administer Formats, Ready-to-Use Formats, Stability Improvement, Liquid Product Technology, Lyo-to-Liquid Conversion, Intravenous To Subcutaneous, High Concentration MAbs, Differentiated Biosimilars, Vaccine Stability Biopharmaceuticals, Ophthalmology, Nitric Oxide-donating Drugs, Inflammation, Cardiovascular Diseases, Osteoarthritis, Glaucoma Treatment, Respiratory Disorders, Allergic Rhinitis, Hypertension Treatment, Skin Disorders, Diabetic Retinopathy, Collaborations, Drug Development
Website
arecor.com nicox.com
Arecor Therapeutics logo

About Arecor Therapeutics

Arecor Therapeutics, founded in 2007 and headquartered in the United Kingdom, is making strides in the biopharmaceutical industry. The company's slogan, "Advancing today’s therapies to enable healthier lives," reflects its mission to transform patient care through the enhancement of existing therape...

Nicox logo

About Nicox

Nicox, an international ophthalmic R&D company, has been dedicated to maintaining vision and improving ocular health since its establishment in 1996. With a focus on biotechnology, healthcare, and medical devices, the company is committed to building a diversified portfolio of therapeutic products t...

We will tell you when either one moves

BounceWatch watches Arecor Therapeutics and Nicox for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Arecor Therapeutics and Nicox — by email.

Frequently Asked Questions

Arecor Therapeutics — Advancing today’s therapies to enable healthier lives. Nicox — Maintain vision and improve ocular health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Arecor Therapeutics has raised $26.56M while Nicox has raised $197.30M.
Arecor Therapeutics and Nicox operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Arecor Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arecor Therapeutics on 11 Mar 2026, and Nicox on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy